These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 2529067)
1. Ramipril reduces albuminuria in diabetic rats fed a high protein diet. O'Brien RC; Cooper ME; Allen TJ; Jerums G Clin Exp Pharmacol Physiol; 1989 Aug; 16(8):675-80. PubMed ID: 2529067 [TBL] [Abstract][Full Text] [Related]
2. Salt blocks the renal benefits of ramipril in diabetic hypertensive rats. Fabris B; Jackson B; Johnston CI Hypertension; 1991 Apr; 17(4):497-503. PubMed ID: 1826492 [TBL] [Abstract][Full Text] [Related]
3. High salt diet ameliorates effects of angiotensin converting enzyme inhibition in spontaneously hypertensive streptozotocin diabetic rats. Jackson B; Fabris B; Paxton D; Franze L; Johnston CI Clin Exp Pharmacol Physiol; 1990 Mar; 17(3):229-34. PubMed ID: 2140303 [TBL] [Abstract][Full Text] [Related]
4. Small doses of ramipril to reduce microalbuminuria in diabetic patients with incipient nephropathy independently of blood pressure changes. Marre M; Hallab M; Billiard A; Le Jeune JJ; Bled F; Girault A; Fressinaud P J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S165-8. PubMed ID: 1725033 [TBL] [Abstract][Full Text] [Related]
5. Combined inhibition of neutral endopeptidase with angiotensin converting enzyme or endothelin converting enzyme in experimental diabetes. Tikkanen I; Tikkanen T; Cao Z; Allen TJ; Davis BJ; Lassila M; Casley D; Johnston CI; Burrell LM; Cooper ME J Hypertens; 2002 Apr; 20(4):707-14. PubMed ID: 11910307 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of both neutral endopeptidase and endothelin-converting enzyme by SLV306 reduces proteinuria and urinary albumin excretion in diabetic rats. Thöne-Reinke C; Simon K; Richter CM; Godes M; Neumayer HH; Thormählen D; Hocher B J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S76-9. PubMed ID: 15838365 [TBL] [Abstract][Full Text] [Related]
7. Renal antifibrotic effect of N-acetyl-seryl-aspartyl-lysyl-proline in diabetic rats. Castoldi G; di Gioia CR; Bombardi C; Preziuso C; Leopizzi M; Maestroni S; Corradi B; Zerbini G; Stella A Am J Nephrol; 2013; 37(1):65-73. PubMed ID: 23327833 [TBL] [Abstract][Full Text] [Related]
8. [Dissociation of hypotensive and renal hemodynamic effects of an angiotensin converting enzyme inhibitor in insulin-dependent diabetic patients with incipient nephropathy]. Hallab M; Billiard A; Lejeune JJ; Bled F; Girault A; Fressinaud P; Marre M Arch Mal Coeur Vaiss; 1991 Mar; 84(3):383-6. PubMed ID: 1828659 [TBL] [Abstract][Full Text] [Related]
9. The effect of urapidil and ramipril on hyperglycemia in streptozotocin diabetic rats. Ittner KP; Zimmermann M; Bucher M; Gessele W; Kees F; Krämer BK; Grobecker HF Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):92-7. PubMed ID: 10651153 [TBL] [Abstract][Full Text] [Related]
10. Glomerular filtration rate in early experimental diabetes. O'Brien RC; Allen TJ; Cooper ME; Bach L; Jerums G J Diabet Complications; 1988; 2(1):8-11. PubMed ID: 2968359 [TBL] [Abstract][Full Text] [Related]
11. Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Functional and structural studies. Allen TJ; Cao Z; Youssef S; Hulthen UL; Cooper ME Diabetes; 1997 Oct; 46(10):1612-8. PubMed ID: 9313758 [TBL] [Abstract][Full Text] [Related]
12. Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathy. Thallas-Bonke V; Coughlan MT; Bach LA; Cooper ME; Forbes JM Am J Nephrol; 2010; 32(1):73-82. PubMed ID: 20551625 [TBL] [Abstract][Full Text] [Related]
13. Prevention of albuminuria by aminoguanidine or ramipril in streptozotocin-induced diabetic rats is associated with the normalization of glomerular protein kinase C. Osicka TM; Yu Y; Panagiotopoulos S; Clavant SP; Kiriazis Z; Pike RN; Pratt LM; Russo LM; Kemp BE; Comper WD; Jerums G Diabetes; 2000 Jan; 49(1):87-93. PubMed ID: 10615954 [TBL] [Abstract][Full Text] [Related]
17. The effect of ramipril on albumin excretion in diabetes and hypertension: the role of increased lysosomal activity and decreased transforming growth factor-beta expression. Russo LM; Brammar GC; Jerums G; Comper WD; Osicka TM J Hypertens; 2003 Feb; 21(2):419-28. PubMed ID: 12569274 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of angiotensin-converting enzyme reduces urinary albumin excretion but not regional albumin clearance in experimental diabetes. Huijberts M; Wolffenbuttel B; Crijns F; Kruseman AN; Bemelmans M; Van Essen H; Smits J; Boudier HS Eur J Pharmacol; 1993 Aug; 240(2-3):207-12. PubMed ID: 8243539 [TBL] [Abstract][Full Text] [Related]
19. Effect of an angiotensin-converting enzyme inhibitor on blood pressure and erythropoiesis in rats. Gould AB; Goodman SA Eur J Pharmacol; 1990 Jun; 181(3):225-34. PubMed ID: 2143478 [TBL] [Abstract][Full Text] [Related]
20. Effect of converting enzyme inhibitors on cardiac changes in experimental uremia. Rambausek M; Mall G; Kollmar S; Ritz E Kidney Int Suppl; 1988 Sep; 25():S201-3. PubMed ID: 2972864 [No Abstract] [Full Text] [Related] [Next] [New Search]